Bio-Path Stock Price (NASDAQ:BPTH)

Add to My Stocks
$1.01 $0.07 (6.48%) BPTH stock closing price Sep 19, 2018 (Closing)
Prev Close* : $1.08
Market Cap:
$12.25M
Day Low: $0.89
52 Week Low: $0.89
Open: $1.08
Volume: -
Day High: $1.09
52 Week High: $5.85
Dividend:
0.00

Latest Stock Market News

Latest Articles

Bio-Path News - From Partners

BPTH Stockcharts

View BPTH PE ratio, PS ratio stocks charts and compare with peers.
BPTH Chart
Note: Compare Bio-Path stock price history with the index and industry peers.

Bio-Path Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Bio-Path Returns

ROE
(return on equity)

Bio-Path Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

BPTH Industry Peers

Company Price Change (%)
Intellipharmaceutics (IPCI)2.750.24 (9.56%)
Precision Therp (AIPT)10.05 (4.76%)
Stemline Therapeutics (STML)17.450.22 (1.28%)
Pdl Biopharma (PDLI)2.370.02 (0.85%)
Actinium Pharma (ATNM)0.730 (0%)
Pharmacyclics (PCYC)261.250 (0%)
Xencor (XNCR)45.060.37 (0.81%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Bio-Path Holdings Inc Stock News - Partner Headlines

Bio-Path Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-7.02M-6.75M-5.46M-4.51M-3.26M
Total Operating Expense9M8.48M5.48M4.53M3.26M
View Bio-Path income statement
balance sheet20172016201520142013
Total Assets8.85M12.19M10.75M15.47M5.07M
Total Liabilities-3.95M---
Shareholders Equity8.06M8.24M9.81M14.91M4.78M
View Bio-Path balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-0.2M-0.67M-0.1M--
Net Cash from (used by) Operating Activities-7.95M-8.14M-5M-3.81M-2.31M
Increase (Decrease) in Prop Plant And Equipment-0.53M-0.33M--0.12M-
View Bio-Path cash flow statement

Bio-Path Stock Message Board

Bio-Path stock lost 6.48%, and the last close price as of Sep 19, 2018 is $1.01 for BPTH stock. Looking at Bio-Path market capitalization, which currently stands at $12.25M, we can say that BPTH stock is a Nano Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Bio-Path stock analysis.

The terms stocks and shares mean the same thing. For Ex: Bio-Path stock price and Bio-Path share price mean the same thing. 86,749 BPTH shares were traded yesterday, and Bio-Path stock chart shows that the BPTH stock quote hit a day high of $1.09 and day low of $0.89. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Bio-Path does not pay dividends. Bio-Path stock price history, gives the entire historical data for BPTH stock.